ArticleHeliyon2024

Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial.

Masoud Solaymani-Dodaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.